Kalytera Therapeutics Inc (KLY.CA) Stock News

TSX-V:KLY - TSX Venture Exchange -

0.045 0 (0%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

KLY.CA Latest News, Press Relases and Analysis

All

Press Releases

4 years ago - By: Claritas Pharmaceuticals, Inc. - Mentions: CLAS.CA CLAS.CA OTC

Claritas Secures $5 Million Equity Financing Facility with Alumina Partners (Ontario) Ltd.

4 years ago - By: Claritas Pharmaceuticals, Inc. - Mentions: CLAS.CA CLAS.CA OTC

Claritas to Develop R-107 for Treatment of PPHN, a Potentially Fatal Pulmonary Disorder in Newborns

4 years ago - By: Claritas Pharmaceuticals, Inc. - Mentions: CLAS.CA CLAS.CA OTC

Claritas Completes Acquisition of Exclusive Worldwide Rights to Develop and Commercialize R-107 for Pulmonary Disease

4 years ago - By: Claritas Pharmaceuticals, Inc. - Mentions: CLAS.CA CLAS.CA OTC

Claritas Announces Publication of Peer-Reviewed Article Reporting that R-107 Significantly Improved Multi-Organ Function and Survival in an Ovine (Sheep) Model of Sepsis

4 years ago - By: Claritas Pharmaceuticals, Inc. - Mentions: CLAS.CA CLAS.CA OTC

Claritas Provides Update Regarding Phase 1 Clinical Study

4 years ago - By: Claritas Pharmaceuticals, Inc. - Mentions: CLAS.CA CLAS.CA OTC

Claritas Announces Engagement of B. Riley Securities as Sponsor for the Company’s Planned Up-Listing of its Securities to the OTCQB

4 years ago - By: Claritas Pharmaceuticals, Inc. - Mentions: CLAS.CA CLAS.CA OTC

Claritas Announces Closing of Convertible Debenture Financing with Obsidian Global GP, LLC

4 years ago - By: Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions

IIROC Trading Resumption - KLY

5 years ago - By: Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions

News Image

IIROC Trading Halt - KLY